Skip to content

A study to understand what patients with advanced oral cancer and their caregivers expect from treatment.

Understanding Patients and Caregivers expectations on the Treatment for Advanced Oral Cancer: A Prospective Mixed-Methods Study. (UPTAKE Study) - UPTAKE STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/098043
Enrollment
78
Registered
2025-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C069- Malignant neoplasm of mouth, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -For Cohort 1_Group A: Newly diagnosed patients diagnosed with advanced (Stage III and IV) OSCC and their caregivers who are planned to receive curative-intent treatment or have completed treatment for advanced OSCC. -For Cohort 2_Group B: patients diagnosed with advanced (Stage III and IV) OSCC and their caregivers who have completed treatment within a year. -For Cohort 3_Group C: patients diagnosed with advanced (Stage III and IV) OSCC and their caregivers who have completed treatment greater than 1 year. -Aged greater than or equal 18 years. -Willing to provide informed consent.

Exclusion criteria

Exclusion criteria: -Patients with recurrent or metastatic disease. -Patients unfit for adjuvant therapy. -Cognitive or psychiatric conditions limiting their ability to participate in interviews.

Design outcomes

Primary

MeasureTime frame
To explore and analyse the patient s and caregiver s expectations of treatment outcomes for advanced OSCCTimepoint: -Pre-therapy: After diagnosis but before initiation of treatment -Post-therapy (short-term): Within one year after completion of therapy -Post-therapy (long-term): More than one year after completion of therapy

Secondary

MeasureTime frame
-To explore if the priorities change across time points. oPre-therapy (after cancer has been diagnosed but before therapy has begun) oPost-therapy, short-term (within the first year after the end of therapy) oPost-therapy, long-term (for survivors who have been living at least three years without relapses after therapy) -To identify factors influencing patient expectations, such as socio-demographic background, prior knowledge, & healthcare provider communication. -To explore emotional, psychological, & social concerns related to treatment & recovery. Timepoint: -Pre-therapy: After diagnosis but before initiation of treatment -Post-therapy (short-term): Within 1 year after completion of therapy -Post-therapy (long-term): More than 1 year after completion of therapy -During data analysis: After completion of data collection for all three time points (for triangulation & comparison)

Countries

India

Contacts

Public ContactDr Shivakumar Thiagarajan

Tata Memorial Hospital

thiagarajans@tmc.gov.in9846572399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026